Psoriasis drug sickens patient

The FDA issued a warning yesterday confirming that another patient taking the psoriasis drug Raptiva developed a rare form of brain infection called progressive multifocal leukoencephalopathy (PML). The warning came after Genentech reported that a 47 year old man in Germany had been hospitalized for the infection. Two other patients--a 70 year old and a 73 year old--died of PML in October and November of last year. All of the patients who developed PML were taking the psoriasis drug for more th

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The FDA issued a warning yesterday confirming that another patient taking the psoriasis drug Raptiva developed a rare form of brain infection called progressive multifocal leukoencephalopathy (PML). The warning came after Genentech reported that a 47 year old man in Germany had been hospitalized for the infection. Two other patients--a 70 year old and a 73 year old--died of PML in October and November of last year. All of the patients who developed PML were taking the psoriasis drug for more than three years. The drug already carries a black-box warning, the sternest warning required by the FDA. In response, Tara Cooper, spokesperson for Genentech, said, "As a company, we take the risk of PML very seriously and we're working with the FDA to put the right plan in place to protect people's safety. We're looking at all possible approaches, including a risk minimization plan." Since its approval in 2003, more than 46,000 patients have taken Raptiva to combat moderate and severe chronic plaque psoriasis, she said. PML occurs in people with weakened immune systems--organ transplant and AIDS patients, those with cancers like Hodgkin's disease, and those taking immunosuppressant drugs. It occurs when a normally harmless virus, called Polyomavirus JC, flares up and attacks the myelin in the brain. Three patients developed PML while taking the multiple sclerosis drug Tysabri before it was pulled from the market in 2005. Since it was reintroduced in 2006 with more stringent restrictions and warnings, four more cases have been reported, the last in December, 2008.
**__Related stories:__***linkurl:MS drug sickens patient;http://www.the-scientist.com/blog/display/55285/
[16th December 2008]*linkurl: Genentech Builds a Blockbuster-free Road to Billions;http://www.the-scientist.com/article/display/14751/
[7th June 2004]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
December digest cover image of a wooden sculpture comprised of multiple wooden neurons that form a seahorse.
December 2025, Issue 1

Wooden Neurons: An Artistic Vision of the Brain

A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.

View this Issue
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

Merck
Stacks of cell culture dishes, plates, and flasks with pink cell culture medium on a white background.

Driving Innovation with Cell Culture Essentials

MilliporeSigma purple logo
Human iPSC-derived Models for Brain Disease Research

Human iPSC-derived Models for Neurodegenerative Disease Research

Fujifilm
Abstract wireframe sphere with colorful dots and connecting lines representing the complex cellular and molecular interactions within the tumor microenvironment.

Exploring the Inflammatory Tumor Microenvironment 

Cellecta logo

Products

Beckman Logo

Beckman Coulter Life Sciences Introduces the Biomek i3 Benchtop Liquid Handler, a Small but Mighty Addition to its Portfolio of Automated Workstations

brandtech logo

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS) 

Top Innovations 2026 Contest Image

Enter Our 2026 Top Innovations Contest

Biotium Logo

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging